Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration
Authors:
- C. A. AlexanderCAC. A. Alexander
- Brian C GilgerBGBrian C Gilger
- J. A. PiedrahitaJPJ. A. Piedrahita
- 26 August 2011
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 95 (12) , 1749-1754
Abstract
Background Truncation mutations in the elongation of very long chain fatty acids-4 (AF277094, MIM #605512) (ELOVL4) gene cause Stargardt-like macular dystrophy type 3 (STGD3). Mice expressing truncated ELOVL4 develop rapid retinal degeneration, but are poor STGD3 models since mice lack a macula. Photoreceptor topography in the pig retina is more similar to that in humans as it includes the cone rich, macula-like area centralis. The authors generated transgenic pigs expressing human disease-causing ELOVL4 mutations to better model the pathobiology of this macular disease. Methods Pronuclear DNA microinjection and somatic cell nuclear transfer were used to produce transgenic pigs for two different ELOVL4 mutations: the 5 base pair deletion (5 bpdel) and the 270 stop mutation (Y270terEYFP). Retinal transgene expression, morphology and electrophysiology were examined. Results The authors obtained four lines of Y270terEYFP and one line of 5 bpdel transgenic animals. Direct fluorescence microscopy indicated that the Y270terEYFP protein is expressed in photoreceptors and mislocalised within the cell. Immunohistochemical examination of transgenic pigs showed photoreceptor loss and disorganised inner and outer segments. Electroretinography demonstrated diminished responses in both transgenic models. Conclusions These transgenic pigs provide unique animal models for examining macular degeneration and STGD3 pathogenesis.Keywords
This publication has 21 references indexed in Scilit:
- Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscinExperimental Eye Research, 2009
- Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acidsProceedings of the National Academy of Sciences, 2008
- Fatty acid elongases in mammals: Their regulation and roles in metabolismProgress in Lipid Research, 2006
- Dominant Negative Mechanism Underlies Autosomal Dominant Stargardt-like Macular Dystrophy Linked to Mutations in ELOVL4Journal of Biological Chemistry, 2005
- A Novel Mutation in theELOVL4Gene Causes Autosomal Dominant Stargardt-like Macular DystrophyInvestigative Ophthalmology & Visual Science, 2004
- Production of α1,3-Galactosyltransferase-Deficient PigsScience, 2003
- Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigsNature Biotechnology, 2002
- Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer CloningScience, 2002
- Sheep cloned by nuclear transfer from a cultured cell lineNature, 1996
- Transgenic livestock as genetic models of human diseaseReproduction, Fertility and Development, 1994